NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
25/03/2022 07:58
NASDAQ TRADE HALT CONTINUES ANTX.O REASON NOT AVAILABLE AT 03:58 AM
Recent news on AN2 Therapeutics
See all newsBrief: AN2 Therapeutics, Inc. Reports Inducement Grants Under Listing Rule 5635(C)(4)
Brief: An2 Therapeutics Announces Extension Of Funding For Tuberculosis Research Collaboration With Gsk
AN2 Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
AN2 Therapeutics Q2 net loss widens on higher R&D costs
AN2 Therapeutics Inc expected to post a loss of 27 cents a share - Earnings Preview